Cargando…
Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) is known to be a regulator of membranal programmed death ligand 1 (PD-L1) stability and a factor associated with malignancy progression, but the effects and mechanisms of CMTM6 on tumor growth, as well as its potential as a target fo...
Autores principales: | Long, Yiru, Chen, Runqiu, Yu, Xiaolu, Tong, Yongliang, Peng, Xionghua, Li, Fanglin, Hu, Chao, Sun, Jianhua, Gong, Likun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896022/ https://www.ncbi.nlm.nih.gov/pubmed/36484740 http://dx.doi.org/10.1158/2326-6066.CIR-22-0439 |
Ejemplares similares
-
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022) -
Different Immunoregulation Roles of Activin A Compared With TGF-β
por: Li, Fanglin, et al.
Publicado: (2022) -
Identification of CMTM6 and CMTM4 as PD-L1 protein
regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017) -
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022) -
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
por: Wang, Hanfeng, et al.
Publicado: (2022)